NCT02015637 - Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea | Biotech Hunter

Enrollment

460

Participants

Timeline

Start Date

January 23, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 10, 2014

Conditions

Gonorrhea

Interventions

DRUG

Delafloxacin

single dose

DRUG

Ceftriaxone

single dose

Trial Locations (25)

10018

Melinta 304 Study Site, New York

11203

Melinta 304 Study Site, Brooklyn

Melinta 304 Study, Brooklyn

15213

Melinta 304 Study Site, Pittsburgh

16507

Melinta 304 Study, Erie

27405

Melinta 304 Study Site, Greensboro

27701

Melinta 304 Study Site, Durham

30033

Melinta 304 Study, Decatur

30308

Melinta 304 Study, Atlanta

35294

Melinta 304 Study, Birmingham

43231

Melinta 304 Study Site, Columbus

44108

Melinta 304 Study Site, Cleveland

46202

Melinta 304 Study Site, Indianapolis

68114

Melinta 304 Study Site, Omaha

70112

Melinta 304 Study Site, New Orleans

77011

Melinta 304 Study Site, Houston

89109

Melinta 304 Study Site, Las Vegas

90069

Melinta 304 Study Site, Los Angeles

90911

Melinta 304 Study Site, Chula Vista

91942

Melinta 304 Study Site, La Mesa

94103

Melinta 304 Study Site, San Francisco

97204

Melinta 304 Study Site, Portland

98104

Melinta 304 Study Site, Seattle

100461

Melinta 304 Study Site, The Bronx

191007

Melinta 304 Study Site, Philadelphia